Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the health-check domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /dom76025/wp-includes/functions.php on line 6121
Investigating the Use of Topical Ruxolitinib in Chronic Hand Eczema - The Dermatology Digest
Subscribe
Search

Investigating the Use of Topical Ruxolitinib in Chronic Hand Eczema

Significantly more patients who applied ruxolitinib cream 1.5% (Opzelura, Incyte) twice daily achieved Investigator’s Global Assessment-Chronic Hand Eczema (IGA-CHE) treatment success at Week 16 when compared to patients who received vehicle. Linda Stein Gold, MD, Director of Dermatology Clinical Research at Henry Ford Health System in Detroit, MI, reviews the data that was presented at the 2024 Fall Clinical Dermatology Conference in Las Vegas, NV, for the first time.
Print Friendly, PDF & Email